Astellas Pharma US, Inc.

Mark Reisenauer has been appointed vice president of sales and marketing, oncology, at Astellas Pharma US, Inc. Mr. Reisenauer will be responsible for all U.S. commercial activities supporting marketed products, the company’s oncology co-promotion partners and will lead commercial planning for early stage development compounds. He reports to Patrick Shea, senior vice president of marketing and sales.

“Astellas has made significant progress over the last year toward becoming a global category leader in oncology with the integration of OSI oncology and further development of the pipeline. Mark’s breadth of product experience, along with his proven leadership capabilities, will be instrumental in Astellas’ future success in oncology,” said Mr. Shea. “We are excited to add Mark to our management team.”

Mr. Reisenauer has more than 20 years of experience having held sales and marketing positions at Abbott, Pharmacia, Bristol-Myers Squibb and Zeneca. Most recently, he served as senior vice president and chief commercial officer of Micromet, Inc., where he was involved in investor and public relations, clinical strategy, business development, and commercial launch planning.